jh tech glp 1 Engineered GLP-1R-targeting nanoplatforms: multimodal therapeutics in human diseases GLP-1 Agonists in Cardiovascular Diseases:
Description
it is a metabolic intervention that must be guided by functional and body composition outcomes
The use of GLP-1RA is a new therapeutic strategy that addresses both metabolic and cognitive/neuropsychiatric aspects, which is fundamentally important for the treatment of comorbid diseases.
Micro-dose GLP-1 supports metabolic balance and consistency as part of a sustainable, long-term wellness routine.
The once-daily pill uses drug delivery technology the company acquired in 2020
It represents a fundamental shift in how obesity should be treated in clinical practice
NBCs senior medical correspondent Dr
